A new test to analyze histone protein modifications in DNA.
HistoneScan™: a multiplex immunoassay for histone epigenetic profiling
This study is testing a new test called HistoneScan™ that can check for different changes in proteins related to gene activity all at once, which could help doctors understand diseases better and create more effective treatments for patients.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Adeptrix Corporation NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10654855 on NIH RePORTER |
What this research studies
This research focuses on developing a novel multiplex immunoassay called HistoneScan™ that can detect multiple histone modifications simultaneously. By using advanced techniques such as single bead immunoaffinity capture and mass spectrometry, the assay aims to enhance the detection and quantification of complex histone modifications associated with various diseases. This could provide valuable insights into gene activity regulation and its implications for health. Patients may benefit from improved diagnostic capabilities that could lead to better-targeted therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to dysregulated gene activity and histone modifications.
Not a fit: Patients without any known genetic or epigenetic disorders may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnostics and targeted treatments for diseases linked to histone modifications.
How similar studies have performed: While the approach of multiplex immunoassays is gaining traction, this specific method for histone profiling is relatively novel and has not been extensively tested in prior studies.
Where this research is happening
Boston, United States
- Adeptrix Corporation — Boston, United States (Active)
Researchers
- Principal investigator: Bergo, Vladislav — Adeptrix Corporation
- Study coordinator: Bergo, Vladislav
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.